Mounjaro results before and after: what actually changes, and when

Six weeks in: what people typically notice first

Imagine you've collected your first Mounjaro pen, started the 2.5mg dose, and you're wondering whether anything is actually happening. At this stage, the changes are mostly internal. Hunger feels quieter than usual. You stop eating before you'd normally expect to. Food that once seemed automatic (the biscuit with the coffee, the extra portion) starts to feel optional rather than compulsive. That shift in appetite is the mechanism working: tirzepatide activates both the GIP and GLP-1 receptors involved in satiety signalling and gastric emptying, reducing the drive to eat without requiring willpower.

The scale, at this point, may not yet show much. The 2.5mg starter dose is calibrated for tolerability, not maximum effect; the body is adjusting. A question our prescribers hear most weeks is 'why haven't I lost much yet?', and the honest answer is that the full therapeutic dose usually takes two to four months to reach, with titration steps every four weeks. For a realistic picture of what the first month looks like, our one-month results page goes through the data in detail. The changes during weeks one to six set the foundation; the weight loss accelerates as the dose rises.

Side effects are most common at this stage too. Nausea, constipation, and some fatigue are reported by many people starting treatment, and they typically ease within a few days to two weeks as the body settles. They are not a sign that treatment is failing.

Three to six months: where most before-and-after differences become visible

By the time a person reaches their maintenance dose and has been using Mounjaro for three to six months, the results in SURMOUNT-1 (the pivotal trial published in the New England Journal of Medicine) were running at roughly 10–15% body-weight reduction, with continued loss expected through to the 72-week endpoint. That translates to around 10–15 kg for someone who started at 100 kg, and proportionally more for those with higher starting weights.

This is the window where changes tend to become visible in photographs, in clothing, and in health markers. Blood pressure, cholesterol, and blood-sugar levels often improve alongside weight, sometimes substantially. These are the results that make tirzepatide clinically meaningful rather than cosmetically interesting, the NICE appraisal of tirzepatide assessed this broader picture, not just the weight figure on its own.

Progress is not linear. Weeks where the scale barely moves are normal and do not indicate treatment failure. The trial data reflects averages across thousands of participants; any individual's trajectory will have its own rhythm. That is why clinical review at every repeat matters, and why a prescriber rather than an algorithm tracks your progress. You can read more about how the broader evidence base shapes these expectations on our Mounjaro results overview.

What 72 weeks of data actually shows

SURMOUNT-1 ran for 72 weeks and randomised 2,539 adults with obesity. At the 15mg dose, average body-weight reduction was around 20–21%, with some analyses reaching approximately 22.5%. These are genuinely large numbers by the standards of any weight-management medicine. For context, the tirzepatide before-and-after results page breaks down what those percentages mean in kilograms across different starting weights, and if you want to see how those numbers translate into real people's experiences, our page covering before and after pictures of Mounjaro weight loss results brings the data to life with visual examples.

SURMOUNT-5, a head-to-head trial published in 2025, compared tirzepatide directly with semaglutide 2.4mg (Wegovy) over 72 weeks in adults with obesity but without diabetes. Tirzepatide produced a greater average weight reduction. That trial matters because it moves beyond placebo comparisons and places tirzepatide alongside the other licensed option, useful context if you're considering which treatment might suit you.

What the data cannot tell you is exactly what your own results will look like. Starting weight, metabolic health, dose reached, diet quality, activity level, and how long you stay on treatment all shape outcomes. The NHS, NICE, and the prescribing guidance all frame these medicines as part of a broader lifestyle approach, not a standalone fix. Many people find it helpful to look at Mounjaro before and after accounts from others at similar starting points, to build a grounded sense of what a realistic personal trajectory might look like before starting a clinical assessment. You can explore treatment options and begin a free consultation through nume. If you're also thinking about cost, our Mounjaro cost page covers what private treatment involves.